Visus Therapeutics, a biopharmaceutical company for eye care, has named Eric Donnenfeld, MD, to its board of directors.
Visus Therapeutics names Dr. Eric Donnenfeld to its board of directors
Visus Therapeutics, a biopharmaceutical company for eye care, has named Eric Donnenfeld, MD, to its board of directors.